So today is exactly 8 weeks since the last Leronlimab update, and 5 weeks since the last corporate communication (concerning the NP firing). So many PRs could come out at any moment, any one of which could cause a massive short squeeze: (1) partnership, including up front cash; (2) BLA filed for HIV; (3) BTD approved for TNBC, with the additional survival numbers incorporated; (4) top-line Brazil numbers (interim) in severe and/or critical covid; (5) covid EUA anywhere else in the world (ie Phillipines); (6) phase 3 longhauler trial begun; (7) BTD approved for NASH 700mg; ( major non-dilutive financing accomplished; (9) buyout offer; (10) new CEO hired. Now, can you imagine if more than one of these PRs are issued within the same week. I can imagine that. Actually, I expect that........and imminently!